Robotics is playing an ever-increasing role in revolutionizing healthcare. The medical industry is playing a leading role in the adoption of robotics and the pace at which these technologies are being adopted is accelerating. It is therefore not surprising that the market for medical robotics is forecast to grow from $16.6bn to $63.8bn between 2023 and 2032. Several applications of these technologies are justifying further deployment.
Speeding up diagnosis
Intuitive, a U.S. firm, developed a robotic-assisted system and platform called Ion. This tool and the supporting system is geared at conducting bronchoscopies in a minimally invasive way in order to detect lung cancer.
In the UK, the University of York is in the advanced stages of developing a combination of robotics and AI called DAISY. This system aims to speed up the triage process in accident and emergency (A&E) medical settings. Once the system goes past the prototype stage, information gathering in the initial stage of triage will be handled by the robot and a specialist doctor will assess that data before making a triage decision.
These kinds of innovations are set to accelerate the rate at which diagnoses are made and patient care will be enhanced while also reducing the workloads of medical personnel.
Improving surgical precision
Many robotic techniques and tools are hitting the market with the aim of supporting surgeons in their bid to undertake complex surgeries in a way that increases success rates while limiting inherent risks. Joint replacement and heart procedures are just a tip of the areas in which these technologies are transforming healthcare delivery.
The use of robotics is helping to reduce recovery time while also minimizing the pain that patients experience after a surgical procedure.
Advancing telemedicine
It is becoming increasingly common for healthcare to be delivered remotely through the help of robotics. For example, Perceptive, a startup based in Boston, says it completed a dental procedure remotely by leveraging robotic tools and arms powered by analytics using AI.
Swallowable bots like the Pillbot have also been developed to enable endoscopies to be performed remotely.
Enhancing medical training
Medical staff is a major factor in healthcare delivery, and their training is also getting attention from developers of medical robotics. For example, RIA, a humanoid robot, helps medical students undergo training by programing the robot to act like it is a patient with the symptoms of a specified disease. The robot exhibits human-like emotions that help medical students to be grounded in how their patients are likely to behave once the students go to the field.
Robotics has also made its way into the after-care provided to patients after their hospital stays. For example, rehab after stroke or accidents can now be conducted with the help of robotics.
As the different specialized robotics systems become mainstream, healthcare delivery is bound to become more personalized and trigger improved clinical outcomes. Health insurers like Astiva Health can start expecting their policyholders to frequently inquire about coverage for such cutting-edge robotic services over the coming years.
NOTE TO INVESTORS: The latest news and updates relating to Astiva Health are available in the company’s newsroom at https://ibn.fm/Astiva
About BioMedWire
BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.
BMW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer
BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is powered by IBN
